These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29479820)

  • 1. Erythrocyte-Derived Nanoparticles as a Theranostic Agent for Near-Infrared Fluorescence Imaging and Thrombolysis of Blood Clots.
    Vankayala R; Corber SR; Mac JT; Rao MP; Shafie M; Anvari B
    Macromol Biosci; 2018 Apr; 18(4):e1700379. PubMed ID: 29479820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots.
    Colasuonno M; Palange AL; Aid R; Ferreira M; Mollica H; Palomba R; Emdin M; Del Sette M; Chauvierre C; Letourneur D; Decuzzi P
    ACS Nano; 2018 Dec; 12(12):12224-12237. PubMed ID: 30427660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte-Derived Theranostic Nanoplatforms for Near Infrared Fluorescence Imaging and Photodestruction of Tumors.
    Burns JM; Vankayala R; Mac JT; Anvari B
    ACS Appl Mater Interfaces; 2018 Aug; 10(33):27621-27630. PubMed ID: 30036031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
    Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.
    Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD
    Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers.
    Yu H; Palazzolo JS; Zhou J; Hu Y; Niego B; Pan S; Ju Y; Wang TY; Lin Z; Hagemeyer CE; Caruso F
    ACS Appl Mater Interfaces; 2022 Jan; 14(3):3740-3751. PubMed ID: 35019268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-responsive theranostic platform for the timely monitoring and efficient thrombolysis in thrombi of tPA resistance.
    Lin L; Ba Z; Tian H; Qin H; Chen X; Zhou X; Zhao S; Li L; Xue F; Li H; He L; Li X; Du J; Zhou Z; Zeng W
    Nat Commun; 2024 Aug; 15(1):6610. PubMed ID: 39098904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonothrombolysis is effective with recombinant tissue-type plasminogen activator, but not with Abciximab. Results from an in vitro study with whole blood clots and platelet-rich clots.
    Eggers J; Ossadnik S; Hütten H; Seidel G
    Thromb Haemost; 2009 Dec; 102(6):1274-7. PubMed ID: 19967161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy.
    Sahu A; Lee JH; Lee HG; Jeong YY; Tae G
    J Control Release; 2016 Aug; 236():90-9. PubMed ID: 27349352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
    Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
    J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
    Yepes M; Roussel BD; Ali C; Vivien D
    Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.
    Chen JP; Yang PC; Ma YH; Tu SJ; Lu YJ
    Int J Nanomedicine; 2012; 7():5137-49. PubMed ID: 23055726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.